Lyell Immunopharma, Inc. (LYEL) vs Cartesian Therapeutics, Inc. (RNAC)
A side-by-side comparison of Lyell Immunopharma, Inc. and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LYEL
Lyell Immunopharma, Inc.
$8.61HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RNAC
Cartesian Therapeutics, Inc.
$6.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — LYEL vs RNAC
growth of $100 · dividends reinvested · last 5yLYEL -97.3% (-51.5%/yr)RNAC -95.1% (-45.4%/yr)RNAC compounded faster over this window
LYEL RNAC
LYEL vs RNAC: by the numbers
- •LYEL is the larger company ($211M vs $198M market cap).
- •Both run net losses; RNAC's is the smaller (-10422.48% vs -920285.19% net margin).
- •Both shrank revenue over the past five years; RNAC's decline was smaller (-50.01% vs -68.32% CAGR).
Metrics side by side
Valuation
| Metric | LYEL | RNAC |
|---|---|---|
| P/S ratio | 7814.17 | 134.28 |
| P/B ratio | 0.90 | N/A |
Profitability
| Metric | LYEL | RNAC |
|---|---|---|
| Gross margin | -31952.78% | 100.00% |
| Operating margin | -566038.89% | -3099.93% |
| Net margin | -920285.19% | -10422.48% |
| ROE | -106.27% | N/A |
| ROIC | -70.80% | -33.10% |
Growth (annualized)
| Metric | LYEL | RNAC |
|---|---|---|
| Revenue CAGR (5Y) | -68.32% | -50.01% |
| Total return CAGR (5Y) | -48.18% | -44.03% |
Frequently asked
- Which has grown faster, LYEL or RNAC?
- Neither grew: over the past five years both shrank revenue, with RNAC's decline the smaller — LYEL at a -68.32% CAGR versus RNAC at -50.01%.
- How have LYEL and RNAC total returns compared?
- Over the past 5 years, LYEL delivered -48.18% and RNAC delivered -44.03% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.